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 ANALISIS MOLEKULAR DAN KUANTIFIKASI PROTIN UNTUK SISTEM 
KUMPULAN DARAH Rh DI KALANGAN PENDERMA-PENDERMA 
DARAH DI PUSAT DARAH NEGARA, MALAYSIA  
 
 
ABSTRAK 
 
Rh adalah sistem kumpulan darah manusia yang paling polimorfik dan imunogenik, 
dengan lebih 50 antigen kini dikenal pasti. Antigen Rh terletak di atas dua protein, 
RhD dan RhCE: yang pertama membawa antigen D, manakala yang kedua 
membawa antigen C, c, E dan e. Antigen-antigen ini boleh dibahagikan lagi kepada 
pelbagai genotip. Kepentingan klinikal antigen Rh adalah berkaitan dengan 
keupayaan D negatif atau beberapa jenis D varian untuk membentuk antibodi D jika 
terdedah kepada antigen D. Antibodi D adalah punca utama penyakit hemolitik bagi 
janin dan bayi yang baru lahir  dan juga boleh menyebabkan hemolitik transfusi. 
Beberapa faktor boleh merumitkan penentuan status D iaitu termasuk penggunaan 
metodologi dan reagen yang berbeza di mana tindak balasnya juga berbeza dengan 
gen-gen RHD yang polimorfik. Aplikasi teknik molekular untuk mengesan antigen 
Rh amat berguna untuk mengurangkan risiko alloimmunisasi.  Tujuan kajian ini 
adalah untuk mencirikan gen Rh dengan kuantifikasi protin antigen Rh yang sepadan 
di kalangan penderma darah di Pusat Darah Negara (PDN), Kuala Lumpur, 
Malaysia. Seramai 1014 penderma darah yang dikaji yang terdiri daripada 360 
Melayu , 434 Cina , 164 India, dan 56  daripada kumpulan-kumpulan etnik minoriti 
yang lain. Sampel darah yang dikumpul telah difenotip secara serologi dengan 
menggunakan mesin automatik, Olympus PK7200. Kemudian sampel ini diteruskan 
xvi 
 
dengan ujian analisis molekular dengan menggunakan teknik Polymerase Chain 
Reaction, Rentetan Primers Khusus  (PCR- SSP). Kuantifikasi protein dan 
penjujukan automatik telah dijalankan ke atas 120 sampel yang menunjukkan 
perbezaan keputusan di antara serologikal dan analisis molekular. 
Keputusan-keputusan analisis antigen Rh dan gen RH menunjukkan kepelbagaian 
dan taburan yang signifikan di antara semua kumpulan etnik (p <0.001).  Ia 
menunjukkan, CCDDee (R1R1) adalah paling tinggi pada etnik Melayu, ccDDEE 
(R2R2) etnik Cina dan ccee (rr) etnik India. Perbezaan di antara 120 keputusan 
analisa fenotip dan genotip telah diperhatikan. Keputusan percanggahan banyak 
berlaku di dalam alel D di kalangan penderma-penderma darah RhD negatif yang 
menunjukkan perkaitan yang signifikan di antara kumpulan-kumpulan etnik yang 
berbeza. Daripada keputusan yang diperolehi serta kajian-kajian lain, ia 
menunjukkan bahawa kelaziman dan asas molekul varian D di Asia adalah berbeza 
daripada orang-orang dalam populasi Eropah dan Afrika. Penemuan lain di dalam 
kajian ini yang signifikan adalah penemuan pelbagai mutasi novel (23) dan mutasi 
yang telah diterbitkan (5). Perkaitan yang signifikan antara keputusan percanggahan 
dan mutasi ditemui di alel D dan C/c, dan ia juga didapati mempunyai hubungan 
antara mutasi dan tahap pengurangan kepekatan protein RHD. Kepekatan protein 
antara 0 hingga 500 (ng/μl) adalah kepekatan biasa untuk protein RHD, protein 
RHCE dan glikoprotein RhAG. Sebagai kesimpulan, dengan menjalankan ujian 
analisis molekular RH bagi penderma darah, asas molekular yang dikaitkan dengan 
antigen kumpulan darah Rh dan fenotipnya dapat dijelaskan serta mewujudkan 
pangkalan data untuk genotip RH penderma darah dari kumpulan etnik utama di 
Malaysia. 
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MOLECULAR ANALYSIS AND PROTEIN QUANTIFICATION OF Rh 
BLOOD GROUP SYSTEM AMONG BLOOD DONORS AT THE NATIONAL 
BLOOD CENTRE, MALAYSIA 
 
 
ABSTRACT 
 
Rh is the most polymorphic and immunogenic human blood group system, with over 
50 antigens now identified. The Rh antigens are located on two proteins, RhD and 
RhCE: the former carries the D antigen, whilst the latter carries the C, c, E and e 
antigens. These antigens can be further subdivided into various genotypes. The 
clinical significance of the Rh antigen is related to the ability of D negative or some 
D variant types to form anti-D if exposed to D antigens. Anti-D is a major cause of 
Haemolytic Disease of the Fetus and Newborn (HDFN) and also can cause 
Haemolytic Transfusion (HTR). Multiple factors can complicate the determination of 
the D status which include different methods and reagents used that can react 
differently with the polymorphic RHD genes.  Thus, applications of molecular 
techniques for the detection of Rh antigens are useful for reducing the risk of 
alloimmunization.  The aim of this study was to characterize the Rh genes and its 
corresponding Rh antigens protein quantification among blood donors at the National 
Blood Centre (NBC), Kuala Lumpur, Malaysia.  The study subjects were 1014 blood 
donors comprising of 360 Malays, 434 Chinese, 164 Indians, and 56 from other 
minor ethnic groups. Blood samples collected were serologically phenotyped using 
automated machine, Olympus PK7200. Then these samples were subjected to 
molecular analysis by applying the PCR- Sequence Specific Primers (PCR-SSP) 
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technique.  Protein quantification and automated sequencing were performed on 120 
samples with results that showed discrepancies from the serological and molecular 
analysis.   
Results of the analyses of Rh antigens and RH genes showed heterogeneity and there 
was significant distribution between all the ethnic groups (p < 0.001). Also, CCDDee 
(R1R1) was highest in Malays, ccDDEE (R2R2) in Chinese and ccee (rr) in Indians. 
Discrepancies in 120 results between phenotype and genotype analysis were 
observed. Most of the discrepancies were found in allele D among the RhD negative 
blood donors which showed significant association between the different ethnic 
groups.  
These findings, together with other studies, indicate that the prevalence and 
molecular basis of D variants in Asia are different from those in Caucasian and 
African populations. The other significant finding was the discovery of multiple 
novel mutations (23) and published mutations (5) in this study. Significant 
associations between discrepancies in results and mutations were found in allele D 
and C/c and it was also found to be correlated between mutation and degree of 
reduction of RHD protein concentration. The protein range of 0 to 500 (ng/µl) 
concentrations was common in the RHD protein, RHCE protein, and RhAG 
glycoprotein.  In conclusion, performing RH molecular analysis in blood donors 
clarifies the molecular basis associated with Rh blood group antigens and phenotypes 
and provides database for RH genotypes of blood donors from major ethnic groups in 
Malaysia. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Background of the Study  
 
Rh is the most important and complex human blood group system. The Rh blood 
group system was first described more than 70 years ago in 1940. In this report, a 
woman had a transfusion reaction when transfused with blood from her husband 
following the delivery of a stillborn child with erythroblastosis fetalis. Her serum 
agglutinated red blood cells (RBC) from her husband and from 80% of Caucasian 
ABO compatible blood donors with her blood. The woman's serum was found that it 
reacted with 77 percent of blood donors. She had been exposed to blood from her 
fetus and produced an antibody that reacted with it. The same antigen was present in 
the baby's father, explaining the woman's reaction to his blood (Avent & Reid, 2000). 
 
 A year later, Landsteiner and Weiner (1941) reported an antibody made by guinea 
pigs and rabbits when these animals were transfused with rhesus monkey red cells. 
This antibody, which agglutinated 85% of human red cells, was named “Rh” 
(Denise, 1999).  If an individual’s RBC were clumped together by this antiserum, 
they were said to have the Rhesus factor on their RBC, thus termed RhD positive. If 
an individual’s RBC were not agglutinated by the antiserum, they were said to lack 
the Rhesus factor, termed RhD negative.  
 
It is now known that the Rh system is very complex and the most polymorphic, with 
over 50 antigens identified (Peyrard et. al, 2009). The most common antigens of the 
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system are D, C, E, c and e.  The Rh antigen is the most clinically significant antigen 
and can be further subdivided into various phenotypes (Mouro et al., 1993).  The 
clinical significance of the Rh antigen is related to the ability of people who are Rh D 
negative or some D variant types to form anti-D if exposed to D antigens. Anti-D is a 
major cause of Haemolytic Disease of the Fetus and Newborn (HDFN) and can cause 
transfusion reactions (Brecher et al., 2005).  
 
Serologic detection of polymorphic blood group antigens and of phenotypes provides 
a valuable source of appropriate blood samples for study at the molecular level. The 
ability to clone complementary Deoxyribonucleic Acid (DNA) and sequence genes 
encoding the Rh proteins have led to an understanding of the molecular basis 
associated with some of the Rh antigens.  
 
1.1.1 Rh Blood Group System 
The Rh system is the most important of the other commonly utilized blood grouping 
systems. It is known that the Rh system is very complex and our present 
understanding is based on the Fisher-Race System. There are three genes that make 
the Rh antigens: C, D, and E, found on chromosome 1 (Avent & Reid, 2000). There 
are two possible alleles at each locus: c or C; d or D; and e or E. One haplotype 
consisting of c/C, d/D, e/E is inherited from each parent, and the resulting Rh type of 
the individual depends on their inherited genotype (Westhoff, 2004).  The RH genes 
are designated by capital letters, with or without italics, and include erythroid RHD, 
RHCE and RHAG, as well as the non-erythroid homologs expressed in other tissues. 
The different alleles of the RHCE gene are designated RHce, RHCe, and RHcE, 
according to which antigens they encode. The proteins are indicated as RhD and 
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RhCE or according to the specific antigens they carry Rhce, RhCe, or RhcE and 
include erythroid RhAG and those found in other tissues (Westhoff, 2007). The 
haplotypes are given a code as seen in Table 1.1.  
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Table 1.1: The Phenotypes and Genotypes of the Rh Blood Group System 
Phenotypes expressed on cell 
Genotype expressed in DNA 
Fisher-Race Wiener 
D+ C+ E+ c+ e+ (RhD+) 
Dce/DCE RoRz 
Dce/dCE Rory 
DCe/DcE R1R2 
DCe/dcE R1r 
DcE/dCe R2r 
DCE/dce Rzr 
D+ C+ E+ c+ e- (RhD+) 
DcE/DCE R2Rz 
DcE/dCE R2ry 
DCE/dcE Rzr 
D+ C+ E+ c- e+ (RhD+) 
DCe/dCE R1ry 
DCE/dCe Rzr’ 
DCe/DCE R1Rz 
D+ C+ E+ c- e- (RhD+) 
DCE/DCE RzRz 
DCE/dCE Rzry 
D+ C+ E- c+ e+ (RhD+) 
Dce/dCe Ror’ 
DCe/dce R1r 
DCe/Dce R1Ro 
D+ C+ E- c- e+ (RhD+) 
DCe/DCe R1R1 
DCe/dCe R1r’ 
D+ C- E+ c+ e+ (RhD+) 
DcE/Dce R2Ro 
Dce/dcE Ror” 
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DcE/dce R2r 
D+ C- E+ c+ e- (RhD+) 
DcE/DcE R2R2 
DcE/dcE R2r” 
D+ C- E- c+ e+ (RhD+) 
Dce/Dce RoRo 
Dce/dce Ror 
D- C+ E+ c+ e+ (RhD-) 
dce/dCE rry 
dCe/dcE r’r” 
D- C+ E+ c+ e- (RhD-) dcE/dCE r”ry 
D- C+ E+ c- e+ (RhD-) dCe/dCE r’ry 
D- C+ E+ c- e- ( RhD-) dCE/dCE ryry 
D-C+ E- c+ e+ (RhD-) dce/dCe rr’ 
D- C+ E- c- e+ (RhD-) dCe/dCe r’r’ 
D- C- E+ c+ e+ (RhD-) dce/dcE rr” 
D- C- E+ c+ e- (RhD-) dcE/dcE r”r” 
D- C- E- c+ e+ (RhD-) dce/dce rr 
Note:  
An uppercase R is used to describe haplotypes that produce D antigen and a 
lowercase r is used when D is absent. The C or c and E or e Rh antigens carried with 
D are represented by 1 for Ce (R1), 2 for cE (R2), o for ce (Ro), and z for CE(Rz). 
The symbols prime (’) and double prime (”) are used with r to designate the CcEe 
antigens; for example, prime is used for Ce (r’), doubleprime (”) for cE (r”), and “y” 
for CE (ry). The R versus r terminology allows one to convey the common Rh 
antigens present on one chromosome in a single term (a phenotype).  
 
(Adapted from www.wikipedia.org/wiki/Rh_blood_group_system) 
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If an individual’s Rh genotype contains at least one of the C, D, or E antigens, he or 
she is considered as RhD positive individual. Only individuals with the genotype 
dce/dce (rr) are RhD negative. For the purpose of the blood transfusion Rh types, r’r 
and r”r is classified as RhD positive donors. Recipients of blood transfusions with Rh 
types r’ and r” should receive RhD negative (rr) blood. This is to prevent 
sensitization to Rh antigens and subsequent Rh antibody formation. The most 
common Rh antibody is anti-D, but it is possible to form antibodies to c, C, e and E 
as well, and to form combinations of antibodies. There is no anti-d due to the 
complete absence of D antigen (Brecher et al., 2005). 
 
1.1.2 The Rh Genes and Rh Proteins 
Two genes (RHD, RHCE) in close proximity on chromosome 1 encode the 
erythrocyte Rh proteins, RhD and RhCE; one carries the D antigen and the other 
carries CE antigens in various combinations (ce, Ce, cE, or CE) (Figure 1.1/A). The 
genes each have ten exons and are 97% identical (Westhoff, 2007).  
 
RhD and RhCE proteins differ by 32-35 out of 416 amino acids (Figure 1.1/B). 
Individuals who lack the RhD protein most often have a complete deletion of the 
RHD gene (Figure 1.1/A). An important consideration in the immunogenenicity of a 
protein is the degree of foreignness to the host. The large number of amino acid 
changes explains why exposure to RhD antigen can results in a potent immune 
response in a D-negative individual (Westhoff, 2007). 
 
RHCE, expressed in all but rare D-- individuals, encodes both C/c and E/e antigens 
on a single protein. C and c antigens differ by four amino acids, but only the amino 
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acid change Ser103Pro is extracellular (Figure 1.1/B). The E and e antigens differ by 
one amino acid, Pro226Ala, located on the fourth extracellular loop of the protein 
(Avent & Reid, 2000). 
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Figure 1.1: Diagram of the RHD and RHCE Locus and Rh Proteins in RBC 
Membrane.  
A) The two RH genes have opposite orientation, with the 3’ ends facing each 
other. Rh negative Caucasians individuals have a complete deletion of RHD. 
B). The RhD and RhCE proteins are predicted to have twelve transmembrane 
domains. Amino acids positions that differ between RhD and RhCE are shown as 
dark circles on RhD. The amino acids changes responsible for C/c and E/e 
polymorphisms are shown on RhCE.  
 
 (Adapted from Westhoff Connie M., 2007) 
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The RH genes and proteins detailed in Figure 1.1 and Figure 1.2(A) are typical for 
the majority of individuals, and commercial antibody reagents detect expression of 
these conventional D, C, c, E and e antigen shown. The proximity of the two RH 
genes and their inverted orientation augments opportunity for genetic exchange 
(Figure 1.1A). Many RH genes carry point mutations, or have rearrangements and 
exchanges between RHD and RHCE that result from gene conversion events (Yves et 
al., 1991). The latter encode hybrid proteins that have RHCE-specific amino acids in 
RhD or RhD-specific residues in RhCE. These can generate new antigens in the Rh 
blood group system and alter or weaken expressions of the conventional antigens; 
see Figure 1.2B (Westhoff, 2007).  
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Figure 1.2: Diagram of the RHD and RHCE genes.  
The ten RHD exons are shown as white boxes, and the RHCE as grey.  
A) RHD and RHCE genes responsible for the common D, C, c, E and e   antigen 
polymorphism.  
B) Altered RHD; C) Altered RHCE genes indicating the changes often found in 
African-Americans that complicate transfusion, especially for sickle cell patients 
     (Adapted from Westhoff Connie M., 2007)  
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1.1.3 Molecular Basis of Rh Antigens 
Previously, it was only possible to determine the Rh phenotype by serologic typing 
of RBC. This serologic approach can be inconclusive, for instance in Rh phenotyping 
of fetuses, in patients who have recently been transfused, and those harboring large 
quantity of donor red blood cells. In all these cases, Rh genotyping is an option 
(Flegel et al, 2009). Serologic detection of polymorphic blood group antigens and 
phenotypes provide valuable sources of appropriate blood samples for molecular 
studies (Anstee, 2009). Haemolytic Disease of the Fetus and Newborn (HDFN), 
Alloimmune and transfusion reactions are not only due to anti Rh-D antibodies but 
also sometimes to anti-Rh E/e or anti-RH C/c antibodies in such cases (Brecher et al., 
2005).  
 
Numerous reports investigating molecular testing for blood groups in transfusions 
have focused on RhD. RBC serologic typing for D can be challenging in the 
approximately 2% of samples with a weak D or partial D antigens. Individuals with 
partial D, as well as some weak D types, lack anti-D when exposed to conventional 
D. Serologic reagents cannot distinguish the majority of these RBCs from those with 
conventional or normal D. This is due to the different monoclonal antibodies used 
that can affect the level of expression the D antigens and their epitopes. The 
molecular RHD characterization methods can be a complement for serologic method 
to solve those problems (Westhoff, 2007). 
 
Molecular investigation of D variants has revealed that there are numerous different 
phenotypes.  Nucleotide mutations that encode amino acid changes in the D protein 
are a common cause of variant phenotypes.  The position of the substitution is 
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thought to be important in determining the D epitope and hence whether the variant 
can make anti-D (Huang & Ye, 2010).  At least 21 different genetic types of weak D 
antigen have now been found. However, the exact mechanism for low expression of 
D antigen is not clear.  The mutations could interfere with membrane integration of 
D protein, possibly by influencing the interaction of RhD protein with RhAG 
glycoprotein (Flegel et al., 2002).   
 
Other mutations are predicted to be in the extracellular region of the D protein.  It is 
speculated that these mutations result in part of the D antigen mosaic being missing 
and thus affect the D epitope resulting in a qualitative change (partial D phenotype).  
This means that these individuals have the ability to form anti-D if exposed to part of 
the mosaic that they lack.  Partial Ds of this type include DNB, where there is a 
single G to A nucleotide exchange at position 1063, which leads to glycine to serine 
amino acid substitution at codon 355 in extracellular loop 6 (Flegel et al., 2002). 
 
Other partial D phenotypes are due to the substitution of a part of the RHD gene with 
part of the RHCE gene and this produces hybrid genes composed of exons from both 
RHD and RHCE.  Category VI type II of partial D is caused by this type of hybrid 
gene.  In these types of exons, 1 to 3 and 7 to 9 are from RHD, whereas exons 3 to 6 
are from RHCE (Figure 1.3). Such recombination is relatively common in the Rh 
system.  This is because the genes lie in close proximity to each other, are highly 
homologous, and also have numerous repetitive elements which may serve as ‘hot 
spots’ for recombination (Brecher et al., 2005). 
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Figure 1.3: Diagram types of Partial D, Elevated D and Altered D 
Most partial D phenotypes result from replacement of portion of RHD by RHCE, 
which cause elevated D phenotype with concurrent loss of the CE antigen or altered 
CE expression 
(Adapted from Westhoff Connie M., 2007) 
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The ability to make anti-D is important in terms of developing a transfusion strategy 
for D variant patients.  Researchers in Germany have suggested that the common 
European weak D types namely weak D types 1, 2 and 3 cannot make anti-D and 
therefore can and should be transfused with D positive units to save the D negative 
stocks.  However, this and any other policy depends on the testing strategy that can 
detect and identify D variant phenotypes (Bretcher et al., 2005).   
 
1.1.4 RhD Typing Discrepancies 
Multiple factors can complicate the determination of the D status. These include the 
different methods used in various laboratories, the different monoclonal antibodies in 
FDA-licensed reagents that can react differently with variant D antigens. The large 
number of different RHD genes, which can affect both the level of expression and, 
potentially, the structure of the molecule and D-epitopes (Westhoff, 2007).  
 
1.1.5 Justification of this Study 
The Rh system is significant due to several factors. Firstly, Rh antigens are highly 
immunogenic and are of great importance for transfusion medicine. Secondly, Rh 
antigens are complex, which stems from the highly polymorphic genes that encode 
them and there are great differences among races in the frequencies of the RH gene 
complex. Thus the Rh system remains the most polymorphic and immunogenic 
blood group system known in humans until now. Additionally, D antigen is the most 
important Rh antigen; it is a mosaic comprising at least 30 epitopes. 
 
Despite the importance of the Rh antigens in blood transfusion and HDFN, the 
function of its proteins is speculative, and may involve transporting ammonium ions 
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across the RBC membrane and maintaining the integrity of the RBC membrane. 
Substitutions of amino acids that are located in Rh transmembraneous segments may 
affect the function of the Rh protein (Avent & Reid, 2000). The clinical significance 
of the Rh antigen is related to the ability of D negative or some D variant types to 
form anti-D if exposed to D antigens. Anti-D is a major cause of haemolytic disease 
of the HDFN and can cause transfusion reactions (Brecher et al., 2005).  
 
The Rh phenotype (D--) is an example of a rare phenotype but individuals having 
this phenotype can develop haemolytic diseases. Individuals with this Rh phenotype 
produce antibodies to RBC against common Rh antigens through pregnancies or 
transfusions (Bretcher et al., 2005). Furthermore, no blood will be compatible except 
of the same blood group and phenotyped as (D--). These individuals can develop 
alloantibody known as anti Rh 17 that can cause HDFN or HTR if other blood group 
is given (Denise, 1999).  
 
In Malaysia, National Blood Centre (NBC) is the referral center for donors and 
patients with Immunohaematology issues where patients are referred for further 
investigation.  Recently, NBC had identified 3 Bidayuh pregnant mothers who had 
been referred with anti Rh 17 antibodies requiring transfusion and no compatible 
blood was found.  In this situation, their siblings were typed and the process was time 
consuming (Musa et al., 2008). In cases of emergencies, this may be a setback since 
blood is not readily available.  
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In current practice, serological method is used to identify the red cell phenotype. This 
method cannot detect complicated cases, especially the rare Rh blood group since 
sensitivity is not optimum (Anstee, 2005). 
 
In NBC, all cases are investigated by serological methods and not by molecular 
analysis for the identification of Rh blood groups which may be time consuming. It is 
therefore timely to conduct a molecular and protein quantification study and establish 
our local database on Rh blood group system in the Malaysian population. Malaysia 
has a multiracial population comprising Malays, Chinese, and Indians who are the 
major races in Peninsular Malaysia with other ethnic groups especially in East 
Malaysia in the north of Borneo Island. In an effort to gain more insight into the 
molecular background and frequency of RH genotypes, a comprehensive and 
systematic study was undertaken to determine the distribution of Rh genotypes from 
selected ethnic groups among blood donors in NBC, Kuala Lumpur.  
 
This research was conducted at NBC because of its status as the national referral 
centre and the high number of blood donations received daily. In addition, it is hoped 
that a policy for D antigen testing in NBC can be formulated based on the research 
findings. 
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1.2 Objectives 
 
1.2.1 Main Objective 
The main objective of this study was to characterize the RH genes and their 
corresponding Rh antigen proteins quantification among blood donors in the 
National Blood Centre (NBC), Kuala Lumpur. 
 
1.2.2 Specific Objectives 
 
i) To determine the frequency of Rh antigen of the various Rh 
phenotypes among blood donors in NBC. 
ii) To determine the frequency of RH gene of the various RH genotypes 
among blood donors in NBC. 
iii) To determine the RH gene polymorphism among blood donors in 
NBC.  
iv) To determine the mutations of the Rh blood group system among 
blood donors in NBC. 
v) To quantify the corresponding Rh antigen protein among blood 
donors in NBC. 
 
1.3 Research Hypothesis 
 
H1 – There is a difference in the Rh antigen frequency from the various Rh  
        phenotypes among the blood donors in NBC. 
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H2 – There is a difference in the RH gene frequency from the various RH  
        genotypes among the blood donors in NBC. 
 
H3 –There is a variation of RH gene polymorphism among the blood donors in NBC. 
 
H4 – There is heterogeneity in the molecular basis of the Rh blood group system  
        among the blood donors in NBC.  
 
H5 –There is a variation in concentration of Rh protein expression among the blood  
        donors in NBC.  
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 Rh Factor 
 
An individual either has, or does not have, the "Rhesus factor" on the surface of 
his/her red blood cells. This term strictly refers to the most immunogenic D antigen 
of the Rh blood group system. The status is usually indicated by Rh positive (Rh+ 
does have the D antigen) or Rh negative (Rh- does not have the D antigen) suffix to 
the ABO blood type (Avent et al., 2000). However, other antigens of this blood 
group system are also clinically relevant. In contrast to the ABO blood group, 
immunization against Rh occurs only through blood transfusion or placental 
exposure during pregnancy in women (Reid & Francis, 2004). 
 
2.2 Rh Nomenclature 
 
The Rh blood group system has two sets of nomenclatures: one developed by Ronald 
Fisher and R.R. Race, the other by Wiener (Westhoff, 2004). Both systems reflected 
alternative theories of inheritance. The Fisher-Race system, which is more 
commonly in use today, uses the CDE nomenclature. This system was based on the 
theory that a separate gene controls the product of each corresponding antigen. 
However, the d gene was hypothetical, not actual (Daniels, 2007). 
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The Wiener system uses the Rh-Hr nomenclature. This system was based on the 
theory that there is one gene at a single locus on each chromosome, each contributing 
to production of multiple antigens. In this theory, a gene R1 is supposed to give rise 
to the “blood factors” Rh0, rh’, and hr” (corresponding to modern nomenclature of 
the D, C and e antigens) and the gene r to produce rh’ and hr” (corresponding to 
modern nomenclature of the c and e antigens) (Denise, 1999). Notations of the two 
theories are used interchangeably in blood banking (e.g., Rho [D] meaning RhD 
positive). Wiener's notation is more complex and cumbersome for routine use. Easier 
to explain, the Fisher-Race theory has become more widely used (Denise, 1999). 
 
On the other hand, DNA testing has shown that both theories are partially correct. 
There are in fact two linked genes: the RHD gene, which produces a single immune 
specificity (anti-D), and the RHCE gene with double immune specificities (anti-C or 
anti-c with anti-E or anti-e). The CDE notation used in the Fisher-Race nomenclature 
is sometimes rearranged to DCE to more accurately represent the co-location of the 
C and E encoding on the RHCE gene, and to make interpretations easier (Daniels et 
al., 2004). 
 
2.3 Rh System Antigens 
 
The proteins that carry the Rh antigens are transmembrane proteins, whose structure 
suggests that they are ion channels (Patnaik et al., 2012). The main antigens are D, C, 
E, c and e, which are encoded by two adjacent gene loci, the RHD gene which 
encodes the RhD protein with the D antigen (and variants),  and the RHCE gene 
which encodes the RhCE protein with the C, E, c and e antigens (and variants) 
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(Patnaik et al., 2012). There is no d antigen. Lowercase "d" indicates the absence of 
the D antigen (the gene is usually deleted or otherwise nonfunctional). 
 
Rh phenotypes are readily identified by identifying the presence or absence of the Rh 
surface antigens. Most of the Rh phenotypes can be produced by several different Rh 
genotypes (Daniels & Bromilow, 2007). The exact genotype of any individual can 
only be identified by DNA analysis. For transfusion, negative antigen blood is given 
only for the phenotype which is usually clinically significant to ensure a patient is 
not exposed to an antigen they are likely to develop antibodies against. A probable 
genotype may be speculated on, based on the statistical distributions of genotypes in 
the patient's place of origin (Westhoff, 2007). 
 
2.4 RH Gene Polymorphism 
 
Rh antigens constitute a clinically important blood group system mainly because of 
their involvement in haemolytic reactions as extremely potent immunogens (Harvey 
& Anstee, 1993). Besides the major D, C/c, and E/e antigens, a large array of 
qualitative and/or quantitative Rh polymorphisms are encountered in the human 
population (Race et al., 1975). These surface-active markers are carried on Rh 
polypeptides, a family of transmembrane proteins that possess two unusual defining 
features, nonglycosylation and palmitoylation (Cartron, 1999). The Rh polypeptides 
appear to play important roles in RBC membrane structure and physiologic 
processes, as highlighted by the occurrence of chronic but moderate hemolytic 
anemia and stomatocytosis in patients with Rh deficiency syndrome (Agre et al., 
1991). Since the cloning of two Rh complementary DNA (cDNAs), much 
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information has been obtained about their primary structure, erythroid expression, 
and complex interaction with other membrane components (Cartron et al, 1994).  
Whereas biochemical analyses showed that the D, C/c, and Ee antigens reside in at 
least three distinct polypeptides, molecular studies indicated that only two structural 
genes, D and non-D (including ce, Ce, cE, and CE alleles), occur in the human 
genome. Nevertheless, it has remained unclear whether C/c is coexpressed with or 
derived from the E/e allelic series by differential Ribonucleic Acid (RNA) splicing 
(Mouro et al., 1993). It is also yet to be established whether the Rh protein(s) alone 
would be sufficient or whether additional factor(s) would be required for the 
antigenic presentation on the RBC membrane.  
 
Despite these uncertainties, studies on a number of Rh phenotypes at the molecular 
level have provided insight into the underlying genetic mechanisms. Analysis of the 
D category variants indicated that they have taken place via homologous 
recombinations between the D and non-D genes (Rouillac et al., 1995). However, the 
molecular basis for those variants lacking some of the major Rh antigens appears to 
be more heterogeneous. For instance, the absence of D antigen from RBCs, a status 
referred to as Rh-negative, may or may not be associated with D locus deletion 
(Huang et al., 1996). In addition, the D- variants occurred on the background of 
partial deletion or nondeletion of the non-D locus (Huang et al.,1995). The DC- and 
DCW- phenotypes were proposed to result from segmental gene conversion events 
(Cherif–Zahar et al., 1994). The structure and expression of Rh polypeptide genes in 
two unrelated individuals exhibiting the dCCee and DCW- phenotypes.  
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2.5 RH Gene Frequency 
 
Wide racial differences are recognized not only in frequency of Rh phenotypes but 
also at the molecular level (Garratty, 2005). Several RHD, RHC/c, and RHE/e 
genotyping assays have been developed. A number of studies have been carried out 
to assess the frequency of these three molecular backgrounds in Africans and 
Caucasians (Mhammed et al., 2009). There are marked differences in the incidence 
of phenotypes associated with weak and partial D, even in different parts of one 
country (Garratty, 2005). 
 
There are many differences in the incidence of phenotypes associated with weak and 
partial D seen in the African and Oriental population backgrounds but only 3 to 5 
percent or less than one percent of individuals of African and Oriental background, 
respectively, type as RhD negative. In the African and Asian populations the RhD 
negative phenotypes, are often caused by inactive or silent RHD rather than the truly 
gene deletions as found in Caucasians. Approximately one third of RhD negative 
Oriental persons are Rh Del with deletion of the whole RHD gene (Garratty, 2005). 
 
Previously, Hyland et al. (1994) applied restriction fragment length polymorphism 
(RFLP) patterns on Southern blots for Rh genotypes. However, they found a 100% 
correlation for 102 randomly selected blood donors for the RhC, Rhe and RhD 
phenotypes, but only 94.8% for the Rhc and 94.3% for the RhE phenotypes.  
 
The sequence of RH genes may vary with different ethnic groups. It is important to 
be aware of the differences in genetic sequences in order to develop genotyping 
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methods that are reliable in a multiracial population. The Rh blood group system has 
shown significantly different distribution among ethnic groups. In Malaysia, it also 
found that the Rh blood group system had shown significantly different between the 
ethnic group of blood donors as in Table 2.1 (Musa et al., 2012). Table 2.2 shows the 
prevalence of phenotypes and genotypes in England, United Kingdom (UK). 
 
Finally, it is important to remember that much of the recent data on weak D and 
partial D have come from Europe, and some of these reports emphasize major 
differences found in selected areas of a single European country. The incidence of 
various D variants may be different such in countries with larger Asian or African 
populations; they need to relate to statistics gathered in their own countries (Garratty, 
2005). To date in the Asian population, there is limited data on the molecular basis of 
the Rh blood group system and other blood group systems especially in Malaysia. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
